Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 nov. 2015 16h01 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at Stifel 2015 Healthcare Conference

ATLANTA, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
06 nov. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results

ATLANTA, Nov. 6, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat...
02 nov. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Announces Appointment of Mark P. Colonnese as Chief Financial Officer

ATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address...
30 oct. 2015 09h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report First Quarter Fiscal Year 2016 Financial Results on November 6, 2015

ATLANTA, Oct. 30, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
22 sept. 2015 16h15 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at Ladenburg Thalmann 2015 Healthcare Conference

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
22 sept. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Appoints Armando Anido and Michael Dunne, M.D. to Its Board of Directors

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
11 sept. 2015 07h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results

ATLANTA, Sept. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
04 sept. 2015 12h30 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report Fourth Quarter and Fiscal Year 2015 Financial Results on September 11, 2015

ATLANTA, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
02 sept. 2015 08h00 HE | Source: Vaxart, Inc.

Biota Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference

ATLANTA, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
20 août 2015 09h24 HE | Source: Vaxart, Inc.

Biota Advances RSV Program With Commencement of Dosing in Phase 1 Trial for Direct-Acting Antiviral BTA585

ATLANTA, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting...

Page précédente